Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in NNVC — Nanoviricides, Inc.

CIK 1214717 BOSTON, MA
Back to NNVC Full portfolio

Position in NNVC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$298,110
+$93,015 QoQ
Shares Held
216,022
-4.2% QoQ
Ownership
0.998%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 48 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NNVC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. NNVC ranks #385 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in NNVC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $298,110 216,022
2026-03-31 $205,095 225,381
2025-12-31 $197,038 174,371
2025-09-30 $227,980 159,427
2025-06-30 $221,190 157,994
2025-03-31 $180,870 154,590
2024-12-31 $204,937 143,313
2024-09-30 $167,035 111,357
2024-06-30 $186,667 108,528
2024-03-31 $127,007 109,489
2023-12-31 $111,678 109,489
2023-09-30 $146,715 109,489
2023-06-30 $127,986 111,293
2023-03-31 $130,212 111,293
2022-12-31 $123,535 111,293
2022-09-30 $193,132 111,637
2022-06-30 $206,988 110,100
2022-03-31 $226,765 108,500
2021-12-31 $403,620 108,500
2021-09-30 $318,851 68,718
2021-06-30 $302,857 65,271
2021-03-31 $308,079 65,271
2020-12-31 $115,127 40,114
2020-09-30 $154,037 40,114
2020-06-30 $300,052 40,114
2020-03-31 $230,254 40,114